Scholarlink

<p>Gastrointestinal helminths significantly impact equine health, performance, and welfare. The heavy reliance on anthelmintics for parasite control has raised growing concerns about drug resistance. From October 2023 to April 2024, a cross-sectional study was conducted at Asella and Shashemene to estimate helminth prevalence, assess risk factors, and evaluate anthelmintic efficacy in equines. Standard parasitological methods were applied to 382 samples to detect parasite eggs or larvae. The fecal egg count reduction test (FECRT) was used to assess anthelmintic efficacy on 180 naturally infected horses (n = 90) and donkeys (n = 90). At each area, 90 helminth-positive animals, with egg counts ≥ 500 EPG, were assigned to three treatment groups: Fenbendazole, Ivermectin, and a non-treated control. Fecal egg counts were measured on the day of treatment and 14&#xa0;days later. The overall prevalence of gastrointestinal helminths was 72%. A parasite identified includes Strongylus species (63.87%), <i>Strongyloides westeri</i> (4.71%), <i>Oxyuris equi</i> (4.45%), <i>Parascaris equorum</i> (5.5%), <i>Fasciola hepatica</i> (4.97%), Gastrodiscus species (3.1%), Dicrocillium species (1.3%), Schistosoma species (1.1%), and <i>Anoplocephala perfoliata</i> (5.2%). Parasite burden analysis revealed that most of the animals had light (51.0%), or moderate (38.2%) infections, while 10.7% of them were heavily infected. Prevalence varied significantly with animal species, age, and study area. The anthelmintic efficacy study showed resistance to Fenbendazole in horses, while parasites in donkeys remained susceptible to both Fenbendazole and Ivermectin. The findings underscore the importance of GIT parasite control in equines and careful use of anthelmintics to manage resistance and maintain effective parasite control.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Occurrence of gastrointestinal helminthiasis and efficacy of anthelmintics in equines in Shashemene and Asella districts, Oromia, Ethiopia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月7日

查看全文
  • Amanu Marama,
  • Getachew Terefe,
  • Hika Waktole,
  • Hagos Ashenafi,
  • Dinka Ayana,
  • Bekele Megersa

摘要

Gastrointestinal helminths significantly impact equine health, performance, and welfare. The heavy reliance on anthelmintics for parasite control has raised growing concerns about drug resistance. From October 2023 to April 2024, a cross-sectional study was conducted at Asella and Shashemene to estimate helminth prevalence, assess risk factors, and evaluate anthelmintic efficacy in equines. Standard parasitological methods were applied to 382 samples to detect parasite eggs or larvae. The fecal egg count reduction test (FECRT) was used to assess anthelmintic efficacy on 180 naturally infected horses (n = 90) and donkeys (n = 90). At each area, 90 helminth-positive animals, with egg counts ≥ 500 EPG, were assigned to three treatment groups: Fenbendazole, Ivermectin, and a non-treated control. Fecal egg counts were measured on the day of treatment and 14 days later. The overall prevalence of gastrointestinal helminths was 72%. A parasite identified includes Strongylus species (63.87%), Strongyloides westeri (4.71%), Oxyuris equi (4.45%), Parascaris equorum (5.5%), Fasciola hepatica (4.97%), Gastrodiscus species (3.1%), Dicrocillium species (1.3%), Schistosoma species (1.1%), and Anoplocephala perfoliata (5.2%). Parasite burden analysis revealed that most of the animals had light (51.0%), or moderate (38.2%) infections, while 10.7% of them were heavily infected. Prevalence varied significantly with animal species, age, and study area. The anthelmintic efficacy study showed resistance to Fenbendazole in horses, while parasites in donkeys remained susceptible to both Fenbendazole and Ivermectin. The findings underscore the importance of GIT parasite control in equines and careful use of anthelmintics to manage resistance and maintain effective parasite control.